beta-lactams has been researched along with Communicable Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Darko, W; Kufel, WD; Miller, CD; Parsels, KA; Seabury, RW; Steele, JM | 1 |
| Ates, HC; Brasier, N; Cotta, MO; Dincer, C; Eckstein, J; Gao, W; Goldhahn, J; Roberts, JA; Sempionatto, JR; Widmer, AF | 1 |
| Bassetti, M; Giacobbe, DR; Vena, A | 1 |
| Cotta, MO; Dulhunty, JM; Lipman, J; Myburgh, J; Roberts, JA | 1 |
| Colton, BJ; George, JM; Rodvold, KA | 1 |
| Kumana, CR; Lee, N; Yuen, KY | 1 |
3 review(s) available for beta-lactams and Communicable Diseases
| Article | Year |
|---|---|
A three-level model for therapeutic drug monitoring of antimicrobials at the site of infection.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; beta-Lactams; Communicable Diseases; Drug Monitoring; Humans | 2023 |
Management of nonfermenting gram-negative infections: a critique of the guidelines.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Communicable Diseases; Gram-Negative Bacteria; Humans; Monobactams | 2023 |
Clinical role of beta-lactam/beta-lactamase inhibitor combinations.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Communicable Diseases; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests | 2003 |
3 other study(ies) available for beta-lactams and Communicable Diseases
| Article | Year |
|---|---|
Evaluation of β-lactam therapeutic drug monitoring among US health systems with postgraduate year 2 infectious diseases pharmacy residency programs.
Topics: beta-Lactams; Communicable Diseases; Cross-Sectional Studies; Drug Monitoring; Humans; Pharmacy Residencies; Surveys and Questionnaires; United States | 2022 |
Should β-lactam antibiotics be administered by continuous infusion in critically ill patients? A survey of Australia and New Zealand intensive care unit doctors and pharmacists.
Topics: Anti-Bacterial Agents; Australia; beta-Lactams; Communicable Diseases; Critical Care; Critical Illness; Humans; Infusions, Intravenous; Intensive Care Units; New Zealand; Pharmacists; Physicians; Surveys and Questionnaires | 2016 |
National survey on continuous and extended infusions of antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Communicable Diseases; Drug Administration Schedule; Health Care Surveys; Humans; Infusions, Intravenous; Pharmacy Service, Hospital; Societies, Pharmaceutical; Time Factors; United States; Vancomycin | 2012 |